Cargando…

Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications

Some genetic abnormalities of multiple myeloma (MM) detected more than two decades ago remain major prognostic factors. In recent years, the introduction of cutting-edge genomic methodologies has enabled the extensive deciphering of genomic events in MM. Although none of the alterations newly discov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardona-Benavides, Ignacio J., de Ramón, Cristina, Gutiérrez, Norma C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914805/ https://www.ncbi.nlm.nih.gov/pubmed/33562668 http://dx.doi.org/10.3390/cells10020336

Ejemplares similares

Transcriptional signature of TP53 biallelic inactivation identifies a group of multiple myeloma patients without this genetic condition but with dismal outcome
por: De Ramón, Cristina, et al.
Publicado: (2022)

Genetic Abnormalities in Extramedullary Multiple Myeloma
por: McAvera, Roisin, et al.
Publicado: (2023)

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
por: Teoh, P. J., et al.
Publicado: (2014)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.
por: Sánchez, Cristina De Ramón, et al.
Publicado: (2023)

RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
por: Quwaider, Dalia, et al.
Publicado: (2022)

P846: EXPRESSION SIGNATURE OF TP53 BIALLELIC INACTIVATION IDENTIFIES A GROUP OF MULTIPLE MYELOMA PATIENTS WITHOUT THIS GENETIC CONDITION BUT WITH DISMAL OUTCOME.
por: De Ramón, C., et al.
Publicado: (2022)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability
por: Herrero, Ana B., et al.
Publicado: (2015)

Implications of Heterogeneity in Multiple Myeloma
por: de Mel, Sanjay, et al.
Publicado: (2014)

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
por: Lebel, Eyal, et al.
Publicado: (2022)

Immunological Prognostic Factors in Multiple Myeloma
por: Bębnowska, Dominika, et al.
Publicado: (2021)

Evidence for ABL Amplification in Multiple Myeloma and Therapeutic Implications
por: Huang, He, et al.
Publicado: (2022)

Chromosome 1q21 abnormalities in multiple myeloma
por: Schmidt, Timothy M., et al.
Publicado: (2021)

Impact of Genetic Abnormalities on the Prognoses and Clinical Parameters of Patients with Multiple Myeloma
por: Jekarl, Dong Wook, et al.
Publicado: (2013)

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
por: LIU, NIAN, et al.
Publicado: (2015)

The Genetic Architecture of Multiple Myeloma
por: Prideaux, Steven M., et al.
Publicado: (2014)

Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Allegra, Alessandro, et al.
Publicado: (2021)

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
por: Herrero, Ana B., et al.
Publicado: (2016)

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma
por: Ruiz-Heredia, Yanira, et al.
Publicado: (2021)

Hemostatic Abnormalities in Multiple Myeloma Patients
por: Gogia, Aarti, et al.
Publicado: (2018)

Systemic multiple myeloma and colonic abnormalities
por: Pawlak, Katarzyna M., et al.
Publicado: (2023)

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma
por: Wei, Yujun, et al.
Publicado: (2022)

The Evolution of Prognostic Factors in Multiple Myeloma
por: Hanbali, Amr, et al.
Publicado: (2017)

Therapeutics to harness the immune microenvironment in multiple myeloma
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Factors Regulating microRNA Expression and Function in Multiple Myeloma
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2019)

Prognostic and predictive biomarker developments in multiple myeloma
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2021)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

The therapeutic potential of cell cycle targeting in multiple myeloma
por: Maes, Anke, et al.
Publicado: (2017)

The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities
por: Saltarella, Ilaria, et al.
Publicado: (2022)

Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
por: Cencini, Emanuele, et al.
Publicado: (2023)

Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
por: Bloedjes, Timon A., et al.
Publicado: (2021)

The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
por: Kalff, A, et al.
Publicado: (2012)

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma
por: Weiser Drozdkova, Denisa, et al.
Publicado: (2021)

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
por: Mai, Elias K., et al.
Publicado: (2023)

P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
por: Attucci, I., et al.
Publicado: (2023)

Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
por: Kadam Amare, Pratibha, et al.
Publicado: (2023)

Electroencephalographic Abnormalities in Autism Spectrum Disorder: Characteristics and Therapeutic Implications
por: Precenzano, Francesco, et al.
Publicado: (2020)

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2021)

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gdhkeoo019gah1k06k1tqqikb